Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

SXTP Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 14, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for 60 Degrees Pharmaceuticals Inc (SXTP)

Based on 8 analysts giving stock ratings to 60 Degrees Pharmaceuticals Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
25
Buy
62
Hold
13
Sell
0
Strong Sell
0
60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals Inc. Stock Analysis SXTP

United States Health Care Nano Cap Report:
60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. The company is headquartered in Washington, Washington Dc and currently employs 3 full-time employees. The company went IPO on 2023-07-12. The firm specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. The company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. The company is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
Read More

60 Degrees Pharmaceuticals Inc (SXTP) Chart

Key Statistics of 60 Degrees Pharmaceuticals Inc (SXTP)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.65$1.70

Today's Open

$1.69

Volume

66.02K

P/E Ratio (TTM)

-

52 Week Range

$1.22$10.77

Market Cap

3.96M

Avg. Volume

129.54K

Dividend Yield

-

Financial Metrics & Statements of 60 Degrees Pharmaceuticals Inc (SXTP)

FAQ's for 60 Degrees Pharmaceuticals Inc (SXTP)

  • According to Musaffa’s Shariah screening methodology, 60 Degrees Pharmaceuticals Inc (SXTP) is currently classified as NOT HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes 60 Degrees Pharmaceuticals Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in 60 Degrees Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of 60 Degrees Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of 60 Degrees Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of 60 Degrees Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.